CN Patent

CN107400115A — 一种来那度胺的新结晶及其药物组合物

Assigned to Shanghai Institute of Pharmaceutical Industry · Expires 2017-11-28 · 8y expired

What this patent protects

本申请涉及一种来那度胺的新结晶及其药物组合物。还涉及包含来那度胺新结晶的结晶组合物及其药物组合物，以及它们的用途。本申请提供的来那度胺新结晶具有纯度高、结晶度高、稳定性好、粒径变化小的优点。

USPTO Abstract

本申请涉及一种来那度胺的新结晶及其药物组合物。还涉及包含来那度胺新结晶的结晶组合物及其药物组合物，以及它们的用途。本申请提供的来那度胺新结晶具有纯度高、结晶度高、稳定性好、粒径变化小的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN107400115A
Jurisdiction
CN
Classification
—
Expires
2017-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Pharmaceutical Industry
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.